Nanosonics Limited

ASX NAN.AX

Nanosonics Limited Net Cash Used Provided By Financing Activities for the year ending June 30, 2024: USD -2.00 M

Nanosonics Limited Net Cash Used Provided By Financing Activities is USD -2.00 M for the year ending June 30, 2024, a -11.05% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.
  • Nanosonics Limited Net Cash Used Provided By Financing Activities for the year ending June 30, 2023 was USD -1.80 M, a -32.55% change year over year.
  • Nanosonics Limited Net Cash Used Provided By Financing Activities for the year ending June 30, 2022 was USD -1.36 M, a -75.80% change year over year.
  • Nanosonics Limited Net Cash Used Provided By Financing Activities for the year ending June 30, 2021 was USD -774.53 K, a 13.49% change year over year.
  • Nanosonics Limited Net Cash Used Provided By Financing Activities for the year ending June 30, 2020 was USD -895.32 K, a -176.58% change year over year.
Key data
Date Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure Effect Of Forex Changes On Cash
Market news
Loading...
ASX: NAN.AX

Nanosonics Limited

CEO Mr. Michael C. Kavanagh BSc, M.B.A.
IPO Date May 17, 2007
Location Australia
Headquarters Building A
Employees 466
Sector Health Care
Industries
Description

Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally. The company engages in the manufacturing and distribution of the trophon ultrasound probe disinfector, and its associated consumables and accessories; and research, development, and commercialization of infection control and decontamination products and related technologies. It provides trophon2, an ultrasound probe high level disinfection device; trophon EPR, a low temperature high level disinfection solution for intra-cavity ultrasound probes; and Nanosonics AuditPro, an infection control workflow compliance management solution. Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.

Similar companies

NXT.AX

NEXTDC Limited

USD 9.31

1.94%

PME.AX

Pro Medicus Limited

USD 157.25

0.24%

WTC.AX

WiseTech Global Limited

USD 73.92

-1.10%

APX.AX

Appen Limited

USD 1.59

-5.98%

StockViz Staff

January 15, 2025

Any question? Send us an email